Shrimpton A E, Borowitz D, Swender P
Clinical Pathology, SUNY Health Science Center, Syracuse, New York 13210, USA.
Hum Mutat. 1997;10(6):436-42. doi: 10.1002/(SICI)1098-1004(1997)10:6<436::AID-HUMU4>3.0.CO;2-B.
Upstate New York patients (100) with cystic fibrosis (i.e., 200 CF chromosomes), 72 from the CF center in Syracuse and 28 from a Buffalo CF center, were analyzed for their CF-causing mutations using restriction enzyme digest, single-strand conformation analysis (SSCA), and Heteroduplex (HA) analysis. Polymerase chain reaction (PCR) amplified products from all 27 CFTR exons using primers that included flanking intron junction sequence were investigated. More than 120 known cystic fibrosis transmembrane conductance regulator (CFTR) disease-causing mutations were screened. Four novel CFTR disease-causing mutations were identified (N287Y in exon 6b, 1259insA in exon 8, R1070P in exon 17b, and CF?20kbdel14b-18). A detection rate of 96% of the combined Syracuse and Buffalo population CF chromosomes was obtained.
对纽约州北部患有囊性纤维化的100名患者(即200条CF染色体)进行了分析,其中72名来自锡拉丘兹的CF中心,28名来自布法罗CF中心,采用限制性内切酶消化、单链构象分析(SSCA)和异源双链(HA)分析来检测其导致CF的突变。使用包含侧翼内含子连接序列的引物,对所有27个CFTR外显子的聚合酶链反应(PCR)扩增产物进行了研究。筛查了120多种已知的囊性纤维化跨膜传导调节因子(CFTR)致病突变。鉴定出4种新的CFTR致病突变(外显子6b中的N287Y、外显子8中的1259insA、外显子17b中的R1070P和CF?20kbdel14b - 18)。锡拉丘兹和布法罗人群的CF染色体综合检测率达到了96%。